Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acyclovir for HSV-2 genital shedding suppression
NCT00723229Phase 4Completed
- Sponsor
- University of Washington
- Start
- Aug 2008
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of aciclovir in genital herpes, sponsored by University of Washington. Started Aug 2008; status: completed.
02
Drugs
aciclovir
03
Conditions
genital herpes
Beyond the preview
Go deeper on NCT00723229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00723229.